Dr. Deborah Ann Garvey is a Brooklyn, New York based female chiropractor who is specialized as General Chiropractor. Active license number of Dr. Deborah Ann Garvey as General Chiropractor is X006159-1 in New York. Dr. Deborah Ann Garvey is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Deborah Ann Garvey speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
D.C.
Gender:
Female
Practice Address:
1 74th St, Apt. 5l, Brooklyn, New York, 11209-1858
Phone:
718-208-8524
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1801040134
NPI Enumeration Date:
13 Nov, 2008
NPI Last Update On:
13 Nov, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Deborah Ann Garvey are as mentioned below.
License Number
Specialization
State
Status
X006159-1
Chiropractor
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1 74th St, Apt. 5l Brooklyn, New York
Zip:
11209-1858
Phone Number:
718-208-8524
Fax Number:
--
Patients can reach Dr. Deborah Ann Garvey at 1 74th St, Apt. 5l, Brooklyn, New York or can call to book an appointment on 718-208-8524. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.